Fund shareholders of ENVVENO MEDICAL CORP
ISIN US29415J2050 · United States · LEI 549300KF5KREFECSNV87
- Fund shareholders
- 7
- Of which ETFs
- 1 6 other funds
- Value held
- 145.9K $
- Share of capital
- 2.1 % of 682.7K shares on Jul 28, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 6,287 | 63.7K $ | 0.00 % | 0.92 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 4,357 | 45.5K $ | 0.00 % | 0.64 % | as of Feb 28, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 1,332 | 13.5K $ | 0.00 % | 0.20 % | as of Mar 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 841 | 8.8K $ | 0.12 % | as of Feb 28, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 703 | 7.3K $ | 0.10 % | as of Feb 28, 2026 ↗ | |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 585 | 6.1K $ | 0.09 % | as of Feb 28, 2026 ↗ | |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 103 | 1K $ | 0.00 % | 0.02 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| iShares Micro-Cap ETF iShares Trust | 0.00 % | as of Mar 31, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
Institutional managers
14 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 36,166 | 366.4K $ | as of Mar 31, 2026 |
| CM Management, LLC | 35,714 | 361.8K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 10,455 | 105.9K $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 5,209 | 52.9K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 1,840 | 18.6K $ | as of Mar 31, 2026 |
| Westside Investment Management, Inc. | 1,589 | 16.1K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 542 | 5.5K $ | as of Mar 31, 2026 |
| UBS Group AG | 243 | 2.5K $ | as of Mar 31, 2026 |
| WELLS FARGO & COMPANY/MN | 114 | 1.2K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 76 | 770 $ | as of Mar 31, 2026 |
| OSAIC HOLDINGS, INC. | 7 | 70 $ | as of Mar 31, 2026 |
| GROUP ONE TRADING LLC | 2 | 20 $ | as of Mar 31, 2026 |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 2 | 20 $ | as of Mar 31, 2026 |
| CITIGROUP INC | 1 | 10 $ | as of Mar 31, 2026 |
Declared shareholders of ENVVENO MEDICAL CORP
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Perceptive Advisors LLC and 2 others | 9.99 % | 68,525 | as of Mar 31, 2026 · SCHEDULE 13G |
| Kingdon Capital Management, L.L.C. and 3 others | 5.50 % | 36,166 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of ENVVENO MEDICAL CORP". https://titelia.com/en/stocks/envveno-medical-corp-US29415J2050